Antonin Levy
Antonin Levy
Gustave Roussy and Paris Saclay University
Adresse e-mail validée de
Citée par
Citée par
Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft …
D Callegaro, R Miceli, S Bonvalot, P Ferguson, DC Strauss, A Levy, ...
The Lancet Oncology 17 (5), 671-680, 2016
Targeting a cornerstone of radiation resistance: cancer stem cell
C Moncharmont, A Levy, M Gilormini, G Bertrand, C Chargari, G Alphonse, ...
Cancer letters 322 (2), 139-147, 2012
Radiation-enhanced cell migration/invasion process: A review
C Moncharmont, A Levy, JB Guy, AT Falk, M Guilbert, JC Trone, ...
Critical reviews in oncology/hematology 92 (2), 133-142, 2014
Definition of synchronous oligometastatic non–small cell lung cancer—a consensus report
AMC Dingemans, LEL Hendriks, T Berghmans, A Levy, B Hasan, ...
Journal of Thoracic Oncology 14 (12), 2109-2119, 2019
Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials
C Ferté, M Fernandez, A Hollebecque, S Koscielny, A Levy, C Massard, ...
Clinical Cancer Research 20 (1), 246-252, 2014
Phase I trials of molecularly targeted agents: should we pay more attention to late toxicities
S Postel-Vinay, C Gomez-Roca, LR Molife, B Anghan, A Levy, I Judson, ...
J Clin Oncol 29 (13), 1728-1735, 2011
Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives
H Mirghani, F Amen, Y Tao, E Deutsch, A Levy
Cancer treatment reviews 41 (10), 844-852, 2015
Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial
A Levy, C Massard, JC Soria, E Deutsch
European Journal of Cancer 68, 156-162, 2016
Can immunostimulatory agents enhance the abscopal effect of radiotherapy?
A Levy, C Chargari, A Marabelle, JL Perfettini, N Magné, E Deutsch
European Journal of Cancer 62, 36-45, 2016
Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer: In …
A Levy, M Guckenberger, C Hurkmans, U Nestle, J Belderbos, ...
Interest of diffusion‐weighted echo‐planar MR imaging and apparent diffusion coefficient mapping in gynecological malignancies: A review
A Levy, A Medjhoul, C Caramella, E Zareski, O Berges, C Chargari, ...
Journal of Magnetic Resonance Imaging 33 (5), 1020-1027, 2011
Targeting head and neck cancer stem cells to overcome resistance to photon and carbon ion radiation
G Bertrand, M Maalouf, A Boivin, P Battiston-Montagne, M Beuve, A Levy, ...
Stem Cell Reviews and Reports 10 (1), 114-126, 2014
Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial
E Deutsch, C Lemanski, JP Pignon, A Levy, A Delarochefordiere, ...
Annals of oncology 24 (11), 2834-2838, 2013
Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)
C Lebbe, C Garbe, AJ Stratigos, C Harwood, K Peris, V del Marmol, ...
European Journal of Cancer 114, 117-127, 2019
Radiation therapy and immunotherapy: implications for a combined cancer treatment
A Levy, C Chargari, M Cheminant, N Simon, C Bourgier, E Deutsch
Critical reviews in oncology/hematology 85 (3), 278-287, 2013
Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy …
D Ou, P Blanchard, S Rosellini, A Levy, F Nguyen, RTH Leijenaar, ...
Oral oncology 71, 150-155, 2017
Radiotherapy–immunotherapy combinations–perspectives and challenges
M Mondini, A Levy, L Meziani, F Milliat, E Deutsch
Molecular oncology 14 (7), 1529-1537, 2020
Targeted therapy-induced radiation recall
A Levy, A Hollebecque, C Bourgier, Y Loriot, J Guigay, C Robert, ...
European Journal of Cancer 49 (7), 1662-1668, 2013
Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?
C Bourgier, A Levy, MC Vozenin, E Deutsch
Cancer and Metastasis Reviews 31 (3-4), 699-712, 2012
Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first‐line sunitinib: a medical …
C Porta, A Levy, R Hawkins, D Castellano, J Bellmunt, P Nathan, ...
Cancer medicine 3 (6), 1517-1526, 2014
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20